Literature DB >> 12431893

Primary care physicians' awareness and implementation of screening guidelines for colorectal cancer.

Ami Schattner1, Avi Gilad.   

Abstract

OBJECTIVE: The objective was to determine primary care physicians' (PCPs) familiarity and implementation of screening guidelines for colorectal cancer (CRC) in central Israel.
METHODS: Fifty PCPs were interviewed and 1000 charts of their asymptomatic patients ages 50-70 were examined. All CRC patients treated at the regional Oncology Institute in 1980-1984 and in 1993-1997 were then compared, with emphasis on the event leading to diagnosis and tumor stage.
RESULTS: Almost all PCPs endorsed screening. Fecal occult blood testing (FOBT) was appropriately recommended by 40% (annually), and the use of flexible sigmoidoscopy (FS) was appropriately recommended by 12% of physicians (every 3-5 years). Only four (8%) were correct in the use of both techniques. Most PCPs estimated that >25% of their patients had been screened for CRC. In fact, 92/1,000 had FOBT (9.2%), 14/1,000 had screening FS (1.4%), and 3 patients only had both tests. Only 1.2% of CRC diagnoses in the 1980s (n = 175) and 2.6% in the 1990s (n = 343) were established as a result of screening (P > 0.25, NS). Tumor stage distribution at diagnosis was similar.
CONCLUSIONS: PCPs studied endorse CRC screening but they are not familiar with accepted guidelines and do very little about implementing them, and this has not changed much over the past decade. CRC screening has a potential to markedly decrease mortality, yet the best screening strategy is worthless without physician education and compliance.

Entities:  

Mesh:

Year:  2002        PMID: 12431893     DOI: 10.1006/pmed.2002.1101

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  8 in total

1.  Colorectal cancer screening: physicians' knowledge of risk assessment and guidelines, practice, and description of barriers and facilitators.

Authors:  Maida J Sewitch; Pascal Burtin; Martin Dawes; Mark Yaffe; Linda Snell; Mark Roper; Patrizia Zanelli; Alan Pavilanis
Journal:  Can J Gastroenterol       Date:  2006-11       Impact factor: 3.522

2.  Screening practices of unaffected people at familial risk of colorectal cancer.

Authors:  Driss Ait Ouakrim; Alex Boussioutas; Trevor Lockett; Ingrid Winship; Graham G Giles; Louisa B Flander; Louise Keogh; John L Hopper; Mark A Jenkins
Journal:  Cancer Prev Res (Phila)       Date:  2011-10-26

Review 3.  The evolution of colorectal cancer genetics-Part 1: from discovery to practice.

Authors:  Andrew T Schlussel; Ronald A Gagliano; Susan Seto-Donlon; Faye Eggerding; Timothy Donlon; Jeffrey Berenberg; Henry T Lynch
Journal:  J Gastrointest Oncol       Date:  2014-10

4.  Screening practices of Australian men and women categorized as "at or slightly above average risk" of colorectal cancer.

Authors:  Driss Ait Ouakrim; Trevor Lockett; Alex Boussioutas; Louise Keogh; Louisa B Flander; Ingrid Winship; Graham G Giles; John L Hopper; Mark A Jenkins
Journal:  Cancer Causes Control       Date:  2012-09-26       Impact factor: 2.506

5.  Self-reported familiarity with acute respiratory infection guidelines and antibiotic prescribing in primary care.

Authors:  Jeffrey A Linder; Jeffrey L Schnipper; Ruslana Tsurikova; Lynn A Volk; Blackford Middleton
Journal:  Int J Qual Health Care       Date:  2010-10-08       Impact factor: 2.038

6.  Association of socioeconomic status and receipt of colorectal cancer investigations: a population-based retrospective cohort study.

Authors:  Sheldon M Singh; Lawrence F Paszat; Cindy Li; Jingsong He; Chris Vinden; Linda Rabeneck
Journal:  CMAJ       Date:  2004-08-31       Impact factor: 8.262

Review 7.  The role of primary care physicians in early diagnosis and treatment of chronic gastrointestinal diseases.

Authors:  Aristofanis Gikas; John K Triantafillidis
Journal:  Int J Gen Med       Date:  2014-03-13

Review 8.  Screening for colorectal cancer: the role of the primary care physician.

Authors:  John K Triantafillidis; Constantine Vagianos; Aristofanis Gikas; Maria Korontzi; Apostolos Papalois
Journal:  Eur J Gastroenterol Hepatol       Date:  2017-01       Impact factor: 2.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.